Gritstone bio, Inc.·4

Apr 8, 8:57 PM ET

Corey Lawrence 4

4 · Gritstone bio, Inc. · Filed Apr 8, 2025

Insider Transaction Report

Form 4
Period: 2025-04-04
Transactions
  • Other

    Stcok Option (right to buy)

    2025-04-0438,0000 total
    Exercise: $4.10Exp: 2032-08-11Common Stock (38,000 underlying)
  • Other

    Stock Option (Right to Buy)

    2025-04-0451,8000 total
    Exercise: $0.76Exp: 2034-06-16Common Stock (51,800 underlying)
  • Other

    Stock Option (Right to Buy)

    2025-04-0451,8000 total
    Exercise: $2.19Exp: 2033-06-15Common Stock (51,800 underlying)
Footnotes (4)
  • [F1]Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value.
  • [F2]The options are fully vested.
  • [F3]The option will vest and become exercisable on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date.
  • [F4]The Stock Option shall vest and become exercisable as to 1/36 of the total number of shares subject thereto on each monthly anniversary of the grant date such that the entire number of shares subject to the Stock Option are fully vested and exercisable on the third anniversary of the grant date, subject to Reporting Person's continuing service on the Issuer's board of directors through each vesting date.

Documents

1 file
  • 4
    form4-04092025_120434.xmlPrimary